Clozapine
- Product NDC
- 51862-903
- 11-digit product format
- 518620903
- Labeler code
- 51862
- Product ID
- 51862-903_f61ce48c-fcc3-49d0-b093-c41204d0a1d8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clozapine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mayne Pharma
- Application
- ANDA203807
- Marketing category
- ANDA
- Marketing start
- 2020-10-05
- Marketing end
- 0000-00-00
- Substance
- CLOZAPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51862-903-01 | 51862090301 | 100 TABLET in 1 BOTTLE (51862-903-01) | 100 tablet | 2020-10-05 | 0000-00-00 | No | No | Current |
| 51862-903-05 | 51862090305 | 500 TABLET in 1 BOTTLE (51862-903-05) | 500 tablet | 2021-01-08 | 0000-00-00 | No | No | Current |